Glass packaging — vials, ampoules, tubes, and bottles — contains pharmaceutical products, laboratory reagents, specialty chemicals, and biological samples where the integrity of the seal is inseparable from the safety and efficacy of the contents. Traditional glass-to-glass seals use heat fusion — flame or laser sealing that melts and bonds glass in a single thermal step. Where a physical cap, stopper, or closure must be bonded to glass rather than fused, UV-curable adhesive sealing provides a room-temperature alternative that protects heat-sensitive contents from the thermal excursion that flame sealing would impose. UV spot lamp systems cure these seals in seconds at defined doses, enabling production throughput in pharmaceutical and laboratory packaging operations.
Applications for UV Adhesive Sealing of Glass Containers
Diagnostic vial bonding. Diagnostic reagent vials and sample collection tubes with polymer caps or plugs bonded to glass tubes use UV-curable adhesives that provide hermetic sealing against gas and liquid ingress. The bond must resist the pressure differential from vacuum-filled collection tubes, and must maintain integrity through the temperature range of cold storage and shipping.
Specialty chemical tube sealing. Laboratory reagent tubes, reference standard ampoules, and calibration solution containers use UV adhesive sealing where the contents are incompatible with heat sealing and where the closure system requires adhesive bonding rather than threaded or snap-fit retention.
Pharmaceutical packaging. Some pharmaceutical packaging configurations seal glass components with UV-curable adhesives where tamper evidence, child resistance, or secondary seal requirements are met by an adhesive bond. UV adhesive seals in pharmaceutical packaging must be evaluated for biocompatibility and extractables if the seal is in the drug contact path.
Laboratory slide mounting. Histological and cytological specimens mounted on glass microscope slides are covered with a coverslip bonded with UV-curable mounting medium (mountant). The mountant must be optically clear, refractive-index matched to glass (nd ≈ 1.515), and stable over the decades-long storage life of archived tissue specimens.
Fiber optic ferrule and end-cap sealing. Glass-tipped fiber optic ferrules and optical fiber end assemblies use UV-curable sealants at the glass-ferrule interface to prevent moisture ingress that would degrade the optical connection.
UV Adhesive Requirements for Glass Sealing
Adhesion to glass. UV adhesives bond to glass through physical adhesion and, with silane coupling agent formulations, through covalent chemical bonding to the silica surface. Covalent bonding provides better moisture resistance and long-term durability than physical adhesion alone, particularly in humid environments where moisture can displace physical adhesive bonds from glass surfaces over time.
Hermetic sealing. For applications requiring gas-tight or liquid-tight seals, the UV-cured adhesive must form a continuous, void-free seal at the glass-adhesive interface and through the full adhesive cross-section. Voids, pinholes, or micro-cracks in the cured adhesive provide leak paths that defeat the seal function.
Chemical compatibility with contents. The UV-cured adhesive must not be degraded by or leach components into the sealed contents. For chemical reagent containers, compatibility with the specific reagents must be verified. For pharmaceutical applications, extractables and leachables testing per ICH Q3C and related guidelines is required.
Optical clarity for inspection. Many sealed glass containers must be inspected visually or by automated systems after sealing. UV adhesive at the glass-closure interface must be clear enough to not obscure the inspection view into the container or the sealed interface. Hazy, milky, or discolored adhesive indicates an adhesion or cure problem.
Temperature stability for cold chain. Pharmaceutical and diagnostic glass containers are stored and shipped under cold chain conditions — typically 2–8°C for refrigerated product, -20°C or -80°C for frozen products. UV-cured adhesive seals must maintain their integrity and seal performance at these temperatures without embrittlement or delamination.
UV Spot Lamp Configuration for Glass Sealing Operations
Glass container sealing presents specific UV access geometry requirements:
Radially symmetric UV access. Cylindrical vials and tubes have circular or annular bond lines around the cap or closure perimeter. Simultaneous UV irradiation from multiple sides — using a radially arranged lamp head assembly or a rotating cure stage — cures the full bond perimeter symmetrically without the asymmetric shrinkage that single-sided cure would introduce.
UV access through glass. In most glass container sealing applications, UV radiation reaches the adhesive through the glass tube wall. Standard borosilicate glass (Type I pharmaceutical glass) transmits at 365–405 nm efficiently, allowing UV cure of adhesive at the glass-closure interface when illuminated from outside the tube. If the tube is coated or UV-absorbing, an alternative UV access path (through the closure, from the open end) must be used.
Rotating fixture cure. A common approach for small-diameter glass vials and tubes is to spin the vial in a fixture while a fixed UV spot lamp illuminates the bond line from one side. The rotation exposes the full circumference of the bond to the UV lamp, curing the adhesive uniformly around the perimeter. Rotation speed and lamp irradiance are calibrated to deliver the minimum dose to every point of the bond perimeter.
Multi-head stationary cure. An alternative to rotating fixtures is a fixed array of UV spot lamp heads positioned around the vial at 60°, 90°, or 120° angular intervals, all triggered simultaneously. This approach eliminates the mechanical complexity of rotation but requires multiple lamp heads per cure station.
If you are specifying UV cure systems for glass container or vial sealing operations, Email Us and an Incure applications engineer will recommend the cure configuration appropriate for your container geometry and production throughput.
Pharmaceutical Regulatory Considerations
UV adhesive sealing in pharmaceutical packaging must be evaluated in the context of applicable regulations:
21 CFR Part 211 (GMP for Finished Pharmaceuticals). FDA GMP regulations require that pharmaceutical packaging components and closures be validated for their intended use. UV adhesive seals used in drug packaging must be qualified through process validation demonstrating that the seal meets the required performance specifications under production conditions.
EU GMP Annex 1. For sterile pharmaceutical products, the primary container closure system — including any adhesive seal — must provide a validated sterile barrier. UV adhesive seals in primary sterile packaging must be validated for seal integrity and sterility maintenance.
Extractables and leachables. ICH Q3C guidance on residual solvents and the broader framework of ICH guidelines on extractables/leachables applies to UV adhesive seals that contact the drug product or drug contact surface. UV cure completeness is particularly important — incompletely cured adhesive contributes higher levels of extractable monomers and photoinitiator fragments than fully cured polymer.
Contact Our Team to discuss UV curing system selection for glass tube, vial, and ampoule sealing in your production application.
Visit www.incurelab.com for more information.